05th week of 2022 patent applcation highlights part 11 |
Patent application number | Title | Published |
20220031758 | USE OF ANIMAL ORIGINATED CORNEA MEMBRANE PRODUCTS IN TREATMENT OF EYE AND OUT OF EYE WOUNDS | 2022-02-03 |
20220031759 | COMPOSITION FOR SKIN REGENERATION AND WOUND HEALING, COMPRISING INDUCED EXOSOMES | 2022-02-03 |
20220031760 | COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION | 2022-02-03 |
20220031761 | COMPOSITIONS FOR PROMOTING SKIN REGENERATION, SKIN REJUVENATION, AND WOUND HEALING AND METHODS FOR PREPARATION AND USE THEREOF | 2022-02-03 |
20220031762 | USE OF ENDOTHELIAL PROGENITOR CELLS IN REJUVENATING THE MICROVASCULATURE, PREVENTING AGING AND TREATING AGE-RELATED DISEASES | 2022-02-03 |
20220031763 | ANTI-ACHING SUPPLEMENT | 2022-02-03 |
20220031764 | Compositions for Fecal Floral Transplantation and Methods for Making and Using Them and Devices for Delivering Them | 2022-02-03 |
20220031765 | BACTERIAL STRAINS FOR MEDICAL USES | 2022-02-03 |
20220031766 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2022-02-03 |
20220031767 | MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS | 2022-02-03 |
20220031768 | METHODS OF TREATMENT OF INFECTIONS USING BACTERIA | 2022-02-03 |
20220031769 | STRAIN FOR PREVENTING AND TREATING METABOLIC DISEASES AND USE THEREOF | 2022-02-03 |
20220031770 | Use of Megamonas funiformis in preventing and/or treating metabolic diseases | 2022-02-03 |
20220031771 | MICROENCAPSULATED AND CHROMOSOME INTEGRATED COMPOSITIONS FOR L-DOPA MICROBIOME THERAPY | 2022-02-03 |
20220031772 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2022-02-03 |
20220031773 | Methods and Compositions for Treating Ulcerative Colitis | 2022-02-03 |
20220031774 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING WEISSELLA CIBARIA WIKIM28 AS ACTIVE INGREDIENT | 2022-02-03 |
20220031775 | PROBIOTIC COMPOSITION AND METHOD FOR IMPROVING AN EFFECT OF CHEMOTHERAPEUTIC DRUG OF GEMCITABINE ON INHIBITING PANCREATIC CANCER | 2022-02-03 |
20220031776 | BACTERIOPHAGE FOR MODULATING INFLAMMATORY BOWEL DISEASE | 2022-02-03 |
20220031777 | Methods of Treating Cancer | 2022-02-03 |
20220031778 | METHOD OF REDUCING NEURONAL MICROTUBULE BINDING PROTEIN TAU (TAU) LEVELS | 2022-02-03 |
20220031779 | ONCOLYTIC HERPES SIMPLEX VIRUS AND THERAPEUTIC USES THEREOF | 2022-02-03 |
20220031780 | NOVEL COMPOSITION | 2022-02-03 |
20220031781 | CANNABIS OIL EXTRACTS AND COMPOSITIONS | 2022-02-03 |
20220031782 | HEMP AND PEA FORMULATION AND ITS USE | 2022-02-03 |
20220031783 | Phenylethanoid Glycoside Extract from Acanthus Ilicifolius L., Preparation Method thereof and Use as Anti-liver Injury Medicament | 2022-02-03 |
20220031784 | Method and Compositions for Treating Equine Encephalitis | 2022-02-03 |
20220031785 | METHOD FOR PREPARING AN ERUCA SATIVA EXTRACT AND USE FOR SHAVING | 2022-02-03 |
20220031786 | ANXIETY MANAGEMENT SUPPLEMENT | 2022-02-03 |
20220031787 | AGENT FOR PREVENTING AND/OR TREATING NEURODEGENERATIVE DISEASES | 2022-02-03 |
20220031788 | Anti-Inflammatory Botanical Extract | 2022-02-03 |
20220031789 | METHOD OF CHINESE HERBAL MEDICINE EXTRACT USED FOR TREATING MULTIPLE DISEASES CAUSED BY DRUG RESISTANT BACTERIA INFECTION | 2022-02-03 |
20220031790 | METHOD FOR PRODUCING RED PERILLA LEAF EXTRACT | 2022-02-03 |
20220031791 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING METABOLIC SYNDROME AND PREPARATIONS THEREOF | 2022-02-03 |
20220031792 | COMPOSITION AND METHOD TO HELP MANAGE THE LINGERING EFFECTS OF COVID-19 IN PATIENTS AFTER RECOVERY | 2022-02-03 |
20220031793 | NEUROPROTECTION AND NEUROREGENERATION BY PTEROSTILBENE AND COMPOSITIONS THEREOF | 2022-02-03 |
20220031794 | USE OF EXTRACTS OF THE LEAVES OF LEMON VERBENA (ALOYSIA CITRIODORA) FOR INCREASING THE NEURONAL, CEREBRAL AVAILABILITY OF NEUROTRANSMITTERS SELECTED FROM THE GROUP OF SEROTONIN, DOPAMINE, NORADRENALINE | 2022-02-03 |
20220031795 | COMPOUND FOR TREATING OXIDATIVE STRESS IN MAMMALS | 2022-02-03 |
20220031796 | LIQUID COMPOSITION FOR ORAL USE AND METHOD FOR REDUCING BITTERNESS OF LIQUID COMPOSITION FOR ORAL USE | 2022-02-03 |
20220031797 | PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACID AND CARNOSINE AND RELATIVE USE | 2022-02-03 |
20220031799 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SENGERS SYNDROME | 2022-02-03 |
20220031800 | PEPTIDES FOR TREATING NON-EXUDATIVE MACULAR DEGENERATION AND OTHER DISORDERS OF THE EYE | 2022-02-03 |
20220031801 | METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST | 2022-02-03 |
20220031802 | Low-Dose Stable Formulations of Linaclotide | 2022-02-03 |
20220031803 | ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC | 2022-02-03 |
20220031804 | THERAPEUTIC AGENT OF UREMIA CONTAINING ALARIN AS THE MAIN INGREDIENT | 2022-02-03 |
20220031805 | THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS | 2022-02-03 |
20220031806 | CD80 EXTRACELLULAR DOMAIN FC FUSION PROTEINS FOR TREATING PD-L1 NEGATIVE TUMORS | 2022-02-03 |
20220031807 | METHODS AND PHARMACEUTICAL COMPOSITION REDUCING SKIN INFLAMMATION | 2022-02-03 |
20220031808 | IL-2 MUTEINS AND USES THEREOF | 2022-02-03 |
20220031809 | COMPOUNDS FOR USE IN INDUCING MYOCARDIAL PERFUSION RECOVERY | 2022-02-03 |
20220031810 | FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | 2022-02-03 |
20220031811 | INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION | 2022-02-03 |
20220031812 | Chimeric Proteins and Methods of Use for Treatment of Central Nervous System Disorders | 2022-02-03 |
20220031813 | INHIBITOR OF EXTRACELLULAR TRAP FORMATION IN LEUKOCYTES | 2022-02-03 |
20220031814 | NOVEL NICOTINE DEGRADING ENZYME VARIANTS | 2022-02-03 |
20220031815 | ANIMAL FEED COMPOSITION AND USE THEREOF | 2022-02-03 |
20220031816 | CANCER TREATMENT | 2022-02-03 |
20220031817 | ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCELOSIDE HYDROLASE PRODRUG | 2022-02-03 |
20220031818 | ARGINASE1 POLYPEPTIDES | 2022-02-03 |
20220031819 | COMPOSITIONS FOR INHIBITING TERATOMA FORMATION AND GROWTH COMPRISING TIMP-1 AND TIMP-2 AS EFFECTIVE COMPONENTS | 2022-02-03 |
20220031820 | MODULATION OF GRANZYME K ACTIVITY IN THE TREATMENT OF SKIN CONDITIONS | 2022-02-03 |
20220031821 | XBP1, CD138, AND CS1 PEPTIDES | 2022-02-03 |
20220031822 | CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYPE III DOMAINS AND USES THEREOF | 2022-02-03 |
20220031823 | PERSONALISED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM | 2022-02-03 |
20220031824 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | 2022-02-03 |
20220031825 | IMMUNOLOGICAL ADJUVANT AND VACCINE COMPOSITION INCLUDING STING AGONIST | 2022-02-03 |
20220031826 | Vaccine For The Prevention And Treatment Of C. Difficile Infections And The Use Thereof | 2022-02-03 |
20220031827 | TETANUS TOXOID AND CCL3 IMPROVE DC VACCINES | 2022-02-03 |
20220031828 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | 2022-02-03 |
20220031829 | COMBINED IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE AND HUMAN PAPILLOMAVIRUS | 2022-02-03 |
20220031830 | HIV VACCINE IMMUNOGENS | 2022-02-03 |
20220031831 | IMMUNOGENIC COMPOSITIONS FOR AFRICAN SWINE FEVER VIRUS | 2022-02-03 |
20220031832 | Recombinant Nucleic Acid of Seneca Valley Virus, Recombinant Vaccine Strain and Preparation Method and Use Thereof | 2022-02-03 |
20220031833 | INACTIVATED WHOLE-VIRUS INFLUENZA VACCINE AND METHOD FOR PREPARING SAME | 2022-02-03 |
20220031834 | STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF | 2022-02-03 |
20220031835 | NANOPARTICLE VACCINES WITH NOVEL STRUCTURAL COMPONENTS | 2022-02-03 |
20220031836 | EMULSOMES COMPRISING S-LAYER FUSION PROTEINS AND METHODS OF USE THEREOF | 2022-02-03 |
20220031837 | PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | 2022-02-03 |
20220031838 | MUCOSAL ADJUVANT | 2022-02-03 |
20220031839 | IMMUNITY-INDUCING AGENT COMPRISING ANTIGEN PEPTIDE-ADJUVANT NUCLEOTIDE CONJUGATE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2022-02-03 |
20220031840 | Method of Treatment | 2022-02-03 |
20220031841 | CANCER ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE | 2022-02-03 |
20220031842 | LAG-3 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2022-02-03 |
20220031843 | Stabilized Formulations Containing Anti-CTLA-4 Antibodies | 2022-02-03 |
20220031844 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACID ETHYL ESTERS | 2022-02-03 |
20220031845 | DILUENTS FOR COMPOSITIONS OF CANNABINOIDS AND USES THEREOF | 2022-02-03 |
20220031846 | ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS | 2022-02-03 |
20220031847 | THERAPEUTIC METHODS | 2022-02-03 |
20220031848 | BIOINK FOR 3D DEPOSITION | 2022-02-03 |
20220031849 | NANOPARTICLE ENCAPSULATION TO TARGET G PROTEIN-COUPLED RECEPTORS IN ENDOSOMES | 2022-02-03 |
20220031850 | Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Colorectal Cancer | 2022-02-03 |
20220031851 | COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS | 2022-02-03 |
20220031852 | TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS | 2022-02-03 |
20220031853 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | 2022-02-03 |
20220031854 | COMPOUNDS AND METHODS FOR TREATING GASTROINTESTINAL DISEASE | 2022-02-03 |
20220031855 | Organic Anion Transporting Peptide-Based Cancer Imaging and Therapy | 2022-02-03 |
20220031856 | CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS | 2022-02-03 |
20220031857 | IN VIVO METHODS FOR SELECTING PEPTIDES THAT CROSS THE BLOOD BRAIN BARRIER, RELATED COMPOSITIONS AND METHODS OF USE | 2022-02-03 |
20220031858 | NOVEL LINKERS | 2022-02-03 |